Sohn Catherine A.

CIK 00015551327 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001555132

Recent Transactions

50 trades

Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-07$39.11/sh−26,920→ 0 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-07$10.42/sh+2,895→ 23,639 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-01-07−20,744→ 0 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-07$10.42/sh+20,744→ 20,744 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-01-07−3,281→ 5,805 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-01-07−2,895→ 316 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-07$10.42/sh+3,281→ 26,920 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-06$38.62/sh−2,493→ 0 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-01-06−2,493→ 3,211 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-06$10.42/sh+2,493→ 2,493 total
Purchase
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2026-01-05$4.24/sh+500→ 1,500 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2025-09-25+48,800→ 48,800 total
Award
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2025-09-22+18,000→ 18,000 total
Purchase
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-03-17$5.78/sh+1,000→ 1,000 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2025-02-06+18,600→ 18,600 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2024-09-26+34,900→ 34,900 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2023-09-28+26,100→ 26,100 total
Sale
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2023-08-14$138.16/sh−1,241→ 14,868 total
Award
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2023-08-11+3,075→ 16,109 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2023-03-23+47,000→ 47,000 total
Sale
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2022-08-08$152.32/sh−1,089→ 13,034 total
Award
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2022-08-05+2,561→ 14,123 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2022-06-04$9.50/sh−7,059→ 0 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2022-06-04$9.50/sh+7,059→ 54,069 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2022-05-31+9,474→ 9,474 total
Award
Axcella Health Inc.
Stock Option (Right to Buy)
2022-05-19+20,000→ 20,000 total
Award
Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
2022-05-12+25,000→ 25,000 total
Sale
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2021-08-06$147.96/sh−1,306→ 11,562 total
Award
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2021-07-29+2,246→ 12,868 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2021-06-04+7,059→ 7,059 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2021-06-01$11.64/sh+8,303→ 47,010 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2021-06-01$11.64/sh−8,303→ 0 total
Award
Axcella Health Inc.
Stock Option (Right to Buy)
2021-05-20+20,000→ 20,000 total
Award
Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
2021-05-12+25,000→ 25,000 total
Exercise/Conversion
Jazz Pharmaceuticals plc$JAZZ
Non-Qualified Stock Option (right to buy)
2020-11-04−4,500→ 0 total
Exercise/Conversion
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2020-11-04$46.83/sh+8,000→ 18,622 total
Exercise/Conversion
Jazz Pharmaceuticals plc$JAZZ
Non-Qualified Stock Option (right to buy)
2020-11-04−8,000→ 0 total
Sale
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2020-11-04$152.00/sh−8,000→ 10,622 total
Sale
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2020-11-04$156.00/sh−4,500→ 10,622 total
Exercise/Conversion
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2020-11-04$81.76/sh+4,500→ 15,122 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2020-10-15−2,200→ 0 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2020-10-15$10.36/sh+2,200→ 38,707 total
Sale
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2020-08-07$125.87/sh−931→ 10,622 total
Award
Jazz Pharmaceuticals plc$JAZZ
Non-Qualified Stock Option (right to buy)
2020-08-06+6,765→ 6,765 total
Award
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2020-08-06+2,705→ 11,553 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Right to Buy Restricted Stock Unit (RSU)
2020-06-01+8,303→ 8,303 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2020-05-28−6,000→ 0 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2020-05-28$10.99/sh+6,000→ 36,507 total
Award
Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
2020-05-21+25,000→ 25,000 total
Award
Axcella Health Inc.
Stock Option (Right to Buy)
2020-05-20+11,000→ 11,000 total

Companies

Recent Filings

Address

C/O MAZE THERAPEUTICS, INC. 171 OYSTER POINT BOULEVARD, SUITE 300

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov